Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Global pharmacovigilance & drug safety industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Functionality trends
2.1.4 Mode of delivery trends
2.1.5 End-use trends
Chapter 3 Pharmacovigilance & Drug Safety Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising number of adverse drug reactions (ADRs)
3.2.1.2 Increasing drug safety regulations
3.2.1.3 Advancements in technology
3.2.1.4 Growing drug development and clinical trials
3.2.2 Industry pitfalls & challenges
3.2.2.1 High implementation costs
3.2.2.2 Data security and privacy concerns
3.3 Growth potential analysis
3.3.1 By functionality
3.3.2 By mode of delivery
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Technology landscape
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix, 2022
4.5 Strategy dashboard, 2022
Chapter 5 Pharmacovigilance & Drug Safety Software Market Size and Forecast, By Functionality (USD Million)
5.1 Key trends, by functionality
5.2 Adverse event reporting software
5.3 Drug safety audits software
5.4 Fully integrated software
5.5 Other functionalities
Chapter 6 Pharmacovigilance & Drug Safety Software Market Size and Forecast, By Mode of Delivery (USD Million)
6.1 Key trends, by mode of delivery
6.2 On-premise
6.3 On-demand/Cloud-based (Saas)
Chapter 7 Pharmacovigilance & Drug Safety Software Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Pharmaceutcal & biotechnology companies
7.3 Contract research organizations (CROS)
7.4 Business process outsourcing (BPO) firms
7.5 Other end-users
Chapter 8 Pharmacovigilance & Drug Safety Market Size and Forecast, By Region (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of MEA
Chapter 9 Company Profiles
9.1 Arisglobal
9.2 AB Cube S.A.S.
9.3 Extedo GMBH
9.4 Ennov Solutions Inc.
9.5 United BioSource Corporation
9.6 Oracle Corporation
9.7 Online Business Applications, Inc.
9.8 Sarjen Systems Pvt. Ltd
9.9 United Biosource Corporation
9.10 Umbra Global
9.11 Genpact
